Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)

e.g. "Sirolimus", "アダリムマブ", "MAP2K"

ABCDEFGH I JKLMNOPQRSTUVWXYZother

107 / 286 pathways

No. KEGG PATHWAY   💬 Info on mouse-over
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES
💬 Info on mouse-over
KEGG DRUG
💬 Info on mouse-over
DrugBank 指定難病告示番号
💬 Info on mouse-over
1 Acute myeloid leukemia 💬
1件: RARA 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
2 Adrenergic signaling in cardiomyocytes 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
3 AGE-RAGE signaling pathway in diabetic complications 💬
2件: VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
4 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
5 Alcoholism 💬
1件: DDC 💬 D00558 💬 Carbidopa 9件: 2, 4, 6, 13, 17, 90, 140, 164, 201 💬
6 Alcoholism 💬
2件: DRD1, DRD2 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
7 Aldosterone synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
8 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
9 Alzheimer disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
10 Alzheimer disease 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
11 Amphetamine addiction 💬
2件: CACNA1C, CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
12 Amphetamine addiction 💬
1件: DDC 💬 D00558 💬 Carbidopa 9件: 2, 4, 6, 13, 17, 90, 140, 164, 201 💬
13 Amphetamine addiction 💬
1件: DRD1 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
14 Amphetamine addiction 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
15 Amyotrophic lateral sclerosis 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
16 Apoptosis - multiple species 💬
1件: NGFR 💬 D11028 💬 Cenegermin 1件: 90 💬
17 Arrhythmogenic right ventricular cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
18 Axon guidance 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
19 B cell receptor signaling pathway 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
20 beta-Alanine metabolism 💬
3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
21 Bile secretion 💬
1件: CA2 💬 D00218 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
22 Bile secretion 💬
1件: CA2 💬 D01196 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
23 Bile secretion 💬
1件: CA2 💬 D00653 💬 Dorzolamide 1件: 90 💬
24 Bile secretion 💬
1件: CA2 💬 D07871 💬 Dorzolamide 1件: 90 💬
25 Bladder cancer 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
26 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
27 C-type lectin receptor signaling pathway 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
28 Calcium signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
29 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
30 Calcium signaling pathway 💬
2件: DRD1, DRD5 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
31 Calcium signaling pathway 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
32 Calcium signaling pathway 💬
1件: PTGFR 💬 D08661 💬 Unoprostone 1件: 90 💬
33 Calcium signaling pathway 💬
2件: VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
34 cAMP signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
35 cAMP signaling pathway 💬
3件: DRD1, DRD2, DRD5 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
36 Carbohydrate digestion and absorption 💬
1件: CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
37 Cardiac muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
38 Cellular senescence 💬
1件: CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
39 Cellular senescence 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
40 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D02076 💬 Brimonidine 2件: 13, 90 💬
41 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D07540 💬 Brimonidine 2件: 13, 90 💬
42 cGMP-PKG signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
43 cGMP-PKG signaling pathway 💬
1件: PDE5A 💬 D02229 💬 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
44 cGMP-PKG signaling pathway 💬
1件: PDE5A 💬 D08514 💬 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
45 cGMP-PKG signaling pathway 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
46 Cholinergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
47 Circadian entrainment 💬
2件: CACNA1C, CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
48 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
49 Circadian entrainment 💬
2件: MTNR1A, MTNR1B 💬 D08170 💬 Melatonin 11件: 6, 8, 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
50 Cocaine addiction 💬
1件: DDC 💬 D00558 💬 Carbidopa 9件: 2, 4, 6, 13, 17, 90, 140, 164, 201 💬
51 Cocaine addiction 💬
2件: DRD1, DRD2 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
52 Collecting duct acid secretion 💬
1件: CA2 💬 D00218 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
53 Collecting duct acid secretion 💬
1件: CA2 💬 D01196 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
54 Collecting duct acid secretion 💬
1件: CA2 💬 D00653 💬 Dorzolamide 1件: 90 💬
55 Collecting duct acid secretion 💬
1件: CA2 💬 D07871 💬 Dorzolamide 1件: 90 💬
56 Cortisol synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
57 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
58 Cushing syndrome 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
59 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
60 Cysteine and methionine metabolism 💬
3件: DNMT1, DNMT3A, DNMT3B 💬 D03665 💬 Decitabine 4件: 13, 63, 90, 301 💬
61 Cytokine-cytokine receptor interaction 💬
1件: NGFR 💬 D11028 💬 Cenegermin 1件: 90 💬
62 Dilated cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
63 Dopaminergic synapse 💬
2件: CACNA1C, CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
64 Dopaminergic synapse 💬
1件: DDC 💬 D00558 💬 Carbidopa 9件: 2, 4, 6, 13, 17, 90, 140, 164, 201 💬
65 Dopaminergic synapse 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
66 Dopaminergic synapse 💬
3件: PPP3CA, PPP3CB, PPP3CC 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
67 EGFR tyrosine kinase inhibitor resistance 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
68 Estrogen signaling pathway 💬
1件: RARA 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
69 Fluid shear stress and atherosclerosis 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
70 Focal adhesion 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
71 GABAergic synapse 💬
3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
72 GABAergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
73 Gap junction 💬
2件: DRD1, DRD2 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
74 Gastric acid secretion 💬
1件: CA2 💬 D00218 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
75 Gastric acid secretion 💬
1件: CA2 💬 D01196 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
76 Gastric acid secretion 💬
1件: CA2 💬 D00653 💬 Dorzolamide 1件: 90 💬
77 Gastric acid secretion 💬
1件: CA2 💬 D07871 💬 Dorzolamide 1件: 90 💬
78 Gastric cancer 💬
1件: RARB 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
79 Glucagon signaling pathway 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
80 Glutamatergic synapse 💬
2件: CACNA1C, CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
81 Glutamatergic synapse 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
82 GnRH secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
83 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
84 GnRH signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
85 Growth hormone synthesis, secretion and action 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
86 HIF-1 signaling pathway 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
87 Human cytomegalovirus infection 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
88 Human cytomegalovirus infection 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
89 Human immunodeficiency virus 1 infection 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
90 Human papillomavirus infection 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
91 Human T-cell leukemia virus 1 infection 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
92 Hypertrophic cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
93 Insulin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
94 Kaposi sarcoma-associated herpesvirus infection 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
95 Kaposi sarcoma-associated herpesvirus infection 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
96 Long-term potentiation 💬
1件: CACNA1C 💬 D01908 💬 Nilvadipine 1件: 90 💬
97 Long-term potentiation 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
98 MAPK signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
99 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
100 MAPK signaling pathway 💬
1件: NGFR 💬 D11028 💬 Cenegermin 1件: 90 💬
101 MAPK signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
102 MAPK signaling pathway 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
103 Metabolic pathways 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
104 Metabolic pathways 💬
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00218 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
105 Metabolic pathways 💬
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D01196 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
106 Metabolic pathways 💬
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00653 💬 Dorzolamide 1件: 90 💬
107 Metabolic pathways 💬
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D07871 💬 Dorzolamide 1件: 90 💬
108 Metabolic pathways 💬
1件: DDC 💬 D00558 💬 Carbidopa 9件: 2, 4, 6, 13, 17, 90, 140, 164, 201 💬
109 Metabolic pathways 💬
3件: DNMT1, DNMT3A, DNMT3B 💬 D03665 💬 Decitabine 4件: 13, 63, 90, 301 💬
110 Metabolic pathways 💬
1件: PDE5A 💬 D02229 💬 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
111 Metabolic pathways 💬
1件: PDE5A 💬 D08514 💬 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
112 MicroRNAs in cancer 💬
3件: DNMT1, DNMT3A, DNMT3B 💬 D03665 💬 Decitabine 4件: 13, 63, 90, 301 💬
113 MicroRNAs in cancer 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
114 Morphine addiction 💬
1件: DRD1 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
115 Natural killer cell mediated cytotoxicity 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
116 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D02076 💬 Brimonidine 2件: 13, 90 💬
117 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D07540 💬 Brimonidine 2件: 13, 90 💬
118 Neuroactive ligand-receptor interaction 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
119 Neuroactive ligand-receptor interaction 💬
2件: MTNR1A, MTNR1B 💬 D08170 💬 Melatonin 11件: 6, 8, 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
120 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00244 💬 Betamethasone 6件: 2, 28, 46, 90, 96, 235 💬
121 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00972 💬 Betamethasone 6件: 2, 28, 46, 90, 96, 235 💬
122 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01357 💬 Betamethasone 6件: 2, 28, 46, 90, 96, 235 💬
123 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01402 💬 Betamethasone 6件: 2, 28, 46, 90, 96, 235 💬
124 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01637 💬 Betamethasone 6件: 2, 28, 46, 90, 96, 235 💬
125 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02032 💬 Betamethasone 6件: 2, 28, 46, 90, 96, 235 💬
126 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02286 💬 Betamethasone 6件: 2, 28, 46, 90, 96, 235 💬
127 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00292 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
128 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00975 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
129 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01510 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
130 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01615 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
131 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01632 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
132 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01948 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
133 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02174 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
134 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02591 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
135 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02592 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
136 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01825 💬 Fluocinolone acetonide 1件: 90 💬
137 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00385 💬 Triamcinolone 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
138 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00983 💬 Triamcinolone 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
139 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00984 💬 Triamcinolone 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
140 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00985 💬 Triamcinolone 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
141 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D06216 💬 Triamcinolone 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
142 Neuroactive ligand-receptor interaction 💬
1件: PTGFR 💬 D08661 💬 Unoprostone 1件: 90 💬
143 Neurotrophin signaling pathway 💬
1件: NGFR 💬 D11028 💬 Cenegermin 1件: 90 💬
144 Nitrogen metabolism 💬
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00218 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
145 Nitrogen metabolism 💬
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D01196 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
146 Nitrogen metabolism 💬
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00653 💬 Dorzolamide 1件: 90 💬
147 Nitrogen metabolism 💬
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D07871 💬 Dorzolamide 1件: 90 💬
148 Non-small cell lung cancer 💬
1件: RARB 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
149 Oocyte meiosis 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
150 Osteoclast differentiation 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
151 Oxytocin signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
152 Oxytocin signaling pathway 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
153 Pancreatic cancer 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
154 Pancreatic secretion 💬
1件: CA2 💬 D00218 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
155 Pancreatic secretion 💬
1件: CA2 💬 D01196 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
156 Pancreatic secretion 💬
1件: CA2 💬 D00653 💬 Dorzolamide 1件: 90 💬
157 Pancreatic secretion 💬
1件: CA2 💬 D07871 💬 Dorzolamide 1件: 90 💬
158 Parkinson disease 💬
2件: DRD1, DRD2 💬 D00059 💬 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201 💬
159 Pathways in cancer 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
160 Pathways in cancer 💬
2件: RARA, RARB 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
161 Pathways of neurodegeneration - multiple diseases 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
162 Pathways of neurodegeneration - multiple diseases 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
163 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
164 Phenylalanine metabolism 💬
1件: DDC 💬 D00558 💬 Carbidopa 9件: 2, 4, 6, 13, 17, 90, 140, 164, 201 💬
165 Phospholipase D signaling pathway 💬
1件: PTGFR 💬 D08661 💬 Unoprostone 1件: 90 💬
166 PI3K-Akt signaling pathway 💬
1件: NGFR 💬 D11028 💬 Cenegermin 1件: 90 💬
167 PI3K-Akt signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
168 Prion disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
169 Prion disease 💬
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
170 Propanoate metabolism 💬
1件: ABAT 💬 D00399 💬 Valproic acid 16件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
171 Proteoglycans in cancer 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
172 Proximal tubule bicarbonate reclamation 💬
2件: CA2, CA4 💬 D00218 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
173 Proximal tubule bicarbonate reclamation 💬
2件: CA2, CA4 💬 D01196 💬 Acetazolamide 7件: 13, 86, 90, 115, 155, 225, 230 💬
174 Proximal tubule bicarbonate reclamation 💬
2件: CA2, CA4 💬 D00653 💬 Dorzolamide 1件: 90 💬
175 Proximal tubule bicarbonate reclamation 💬
2件: CA2, CA4 💬 D07871 💬 Dorzolamide 1件: 90 💬
176 Purine metabolism 💬
1件: PDE5A 💬 D02229 💬 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
177 Purine metabolism 💬
1件: PDE5A 💬 D08514 💬 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
178